Cause for optimism at a2 Milk and Invocare: Reporting season roundup |
Tweet | ![]() |
<p><strong>Lewis Jackson</strong>: Hello and welcome to another edition of Morningstar's reporting season wrap. Today I'm joined by Angus Hewitt, who oversees a series of companies ranging from a2 Milk to Qantas.</p>
<p>Angus, thanks for joining us.</p>
<p><strong>Angus Hewitt</strong>: Thanks Lewis.</p>
<p><strong>Jackson</strong>: So, looking across the coverage universe this reporting season, were there any unexpected surprises, whether to the upside or the downside?</p>
<p><strong>Hewitt</strong>: I got a lot of good disclosure this earnings season. So there weren't a lot of surprises from an earnings point of view. But there were a few things that were a little bit interesting when you really started to dig into the results. So on the upside, you've got InvoCare funeral provider, InvoCare, this is one of our best ideas. We really like this company. It's one of few companies in Australia we assign a wide economic moat, and that's underpinned by its series of premium brands in Australia highly respected, well known brands and its cost advantages over a long tail of smaller competitors in what is a highly fragmented funeral market. We already have a pretty good idea of how the pandemic is weighing on InvoCare. That's both on volume and price.</p>
<p>On the volume side deaths in Australia are down. Our handling of the pandemic, lockdowns, restrictions, social distancing, people just washing their hands has led to a virtually non-existent flu season in 2020. And it looks like we're going to have essentially no flu season in 2021 as well. Compounding that you've got on the pricing side when there's restrictions on funeral attendance, InvoCare aren't able to offer their full range of services. So demand for premium services, higher cost, higher margin services, like White Lady have declined in favour of lower cost services with streaming capabilities. So what I sort of found surprising, and to the upside it was good to see how quickly pricing bounced back in periods where restrictions on funeral attendance eased. So that sort of you saw demand for White Lady really bounce back once they were allowed to have funerals with more than 10 people today. And that really indicates the strength of the underlying brands for InvoCare.</p>
<p><strong>Jackson</strong>: So, less deaths is good for everyone, but InvoCare.</p>
<p><strong>Hewitt</strong>: Something like that.</p>
<p><strong>Jackson</strong>: And were there any other names, that surprised in the other direction?</p>
<p><strong>Hewitt</strong>: None that come to mind, no.</p>
<p><strong>Jackson</strong>: Okay. Now turning to a2 Milk. It's a Morningstar best idea. It's been struggling for little bit and earnings were down 70% when it reported last month. Talk us through why you're still optimistic about it.</p>
<p><strong>Hewitt</strong>: Yeah, a2 has been having a rough time, earnings like you said down more than 70%. It wasn't unexpected, we did have a lot of disclosure like I was saying before that this was coming. I will just note, a2 is a – lot of the visibility of a2 in Australia is the fresh milk business. Whereas this is a much smaller part of this company a2 primarily can be viewed as a Chinese infant formula business. The majority the vast majority of its earnings are from sales of infant formula sold directly or indirectly to China. The main concern at the moment is the inventory levels in the English label infant formula, which is being sold through to China. So these high inventory levels has led to lower restocking from the key corporate daigou partners, and also an ageing of the inventory in those channels.</p>
<p><strong>Jackson</strong>: And Angus just quickly when you say daigou, you mean?</p>
<p><strong>Hewitt</strong>: These are reseller channels selling through to China. So they're buying the English label products here in Australia but they're eventually getting shipped off to China. Yeah. So that's the near-term, the real near-term headwind is these inventory levels. A2 has written off $109 million worth of inventory over the period. And they chose to write this off rather than discount to protect their brand. And this is a good move we assign InvoCare, not InvoCare, we assign a2 a narrow economic moat and this is based on its brand, the strength of its brand in China. A2 is first and foremost a brand business. And we still think it has plenty of brand equity in China. If you look at the Chinese label business, which it sells through what are known as mother and baby stores. The market share in these mother and baby stores at June 2021 is 2.5% versus just 2% a year ago, so they're still growing share. But to get to your question, we're still optimistic on a2. We think this is an opportunity to be greedy when others are fearful. There's a lot of pessimism baked into a2 share price. And we think inventory levels have stabilised and we're expecting continued growth in the China label infant formula business.</p>
<p><strong>Jackson</strong>: And with so much importance on the China label side of the business, are you concerned with, the recent tension around China trade tensions and long term the viability of a business so reliant on the Chinese market?</p>
<p><strong>Hewitt</strong>: Yeah, it's definitely a concern. A2, I'd like to point out that they are a New Zealand business, not an Australian business. It's definitely something to think of, but foreign owned formula businesses really dominate the premium side of the market in China. So we're not expecting it to weigh on sales in the near term.</p>
<p><strong>Jackson</strong>: So, keeping our focus sort of international for a minute. Vaccination rates are increasing, the prospect of international travel is back on the agenda, finally. What does all this mean for Qantas? And is it too late for investors to get in on the action?</p>
<p><strong>Hewitt</strong>: Yeah, the situation facing Qantas it probably doesn't need a lot of introduction. So the pandemic has obviously devastated flying across the globe and Australia's decision to close international borders for the last 18 months or so, means that the recovery in Australia significantly trails that of most of the world. This is offset a little bit by the Qantas' highly profitable domestic business when they're allowed to fly. So you've got outbreaks and lockdowns, particularly in Sydney and Melbourne at the moment. And state border restrictions in general is sort of weighing on the near term for Qantas and we're expecting the near term will remain bleak. But and we're expecting fiscal 2022, to be another full year loss as well. But we do expect these to be short term issues. The recovery of air travel will prove highly volatile. We're expecting international travel to return to pre-COVID 2019 levels by 2024.</p>
<p>So there's a fair bit of recovery baked in over the next few years. And Qantas has plenty of financial headroom in the near term to get through a lot of that near term turbulence, and we think it's well positioned to really thrive when the skies reopen. As far as pricing is concerned, shares are trading at around our fair value estimate. There is valuation upside if the vaccination rollout, like you said or pent up demand leads to a quicker than expected recovery in international flying.</p>
<p><strong>Jackson</strong>: And was there any optimism in Qantas' guidance when it reported last month?</p>
<p><strong>Hewitt</strong>: No, there's a lot of uncertainty, there's a little bit of optimism, that they're expecting, they're tying their expectations for international borders to open with vaccination rollout. So if that's late December, is the current estimate, but I'm not expecting all international borders will suddenly reopen and we'll just go back to where we were, it's going to be more gradual. Maybe it'll just be for certain countries and maybe it'll just be for vaccinated travellers, there's a lot to be seen on how this is going to play out. Obviously, Qantas want international flying to return as soon as possible and they want internal state border restrictions to be a thing of the past. But there's still a bit of headwind to get through at the moment.</p>
<p><strong>Jackson</strong>: Don't we all. Angus turning to again, back to the reporting season as a whole you know, you listen to 10s, 10s and 10s of earnings calls last month, was there anything that stood out were there any themes or any interesting questions from analysts, any comments from management that you'd like to draw our attention to?</p>
<p><strong>Hewitt</strong>: Yeah. What I guess what surprised me was how much Treasury Wine likes to name drop Snoop Dogg. Snoop is a brand ambassador for one of their premium wines in the U.S. But what really stood out to me was the the Crown earnings call. For an earnings call there wasn't a lot of focus on earnings. Crown are facing two simultaneous Royal Commissions in Victoria and Western Australia. And a long drawn out process to prove suitability to operate in New South Wales and that really overshadowed both the results and the call as well.</p>
<p><strong>Jackson</strong>: When it comes to your Crown valuation. Crown is currently undervalued and so it's the buy opportunity.</p>
<p><strong>Hewitt</strong>: Yeah, it is. We think all this uncertainty, all this regulatory uncertainty creates buying opportunities. So there's risk. There's risk in investing, of course. But we think Crown will continue to operate in Victoria and Western Australia, and we think will eventually prove suitability in New South Wales and that's underpinned our undervalued rating.</p>
<p><strong>Jackson</strong>: Fantastic. Okay. Well Angus, thank you so much for your insights today.</p>
<p><strong>Hewitt</strong>: Thanks Lewis.</p>

25/05/2022 The Nobel prize winner who cameo'd alongside Selena Gomez in Hollywood hit The Big Short discusses the latest developments in behavioural economics.

19/05/2022 Local investors were spooked after US retail giants Target and Walmart plummeted overnight as rising prices hit margins and inventory.

19/05/2022 On his recent visit to Australia, Morningstar's global chief investment officer Dan Kemp talks investing narratives, confronting the growing list of reasons to be concerned about markets and sustainable investing.

19/05/2022 Worries about inflation’s toll on earnings sparks Wednesday’s 4% plunge, but stocks are now far undervalued.

18/05/2022 One of the big themes of the year has been the value comeback. What is behind this resurgence after a pretty dismal period, and should your portfolio be tilting in its direction?

11/05/2022 Here's what investors who are worried about a recession should consider today.

11/05/2022 Morningstar analysts have identified TPG telecom as the most undervalued telecom stocks in the ASX 200 detailing multiple catalysts for earnings recovery and growth.

29/04/2022 Exclusive: Hermitage Capital Management CEO Bill Browder talks Putin, Russia, and the next six months for Ukraine

28/04/2022 Inflation, rising interest rates, geopolitical risks, and other things to keep your eye on.

27/04/2022 Morningstar's analyst talks about the Buffett's recent deals, what the stock is worth, and whether Berkshire will pay a dividend any time soon.

31/03/2022 Supply disruptions following Russia's invasion of Ukraine are forcing analysts to consider the possibility elevated prices persist.

30/03/2022 Rising interest rates, strong economic growth and cheaper valuations are driving banking stocks ahead of the broader market.

28/03/2022 Where are entertainment and streaming services headed?

24/03/2022 Problems in global supply chains are an opportunity for WiseTech as its logistics company customers move to replace old software.

23/03/2022 Markets focused on floods and bushfires are missing how insurers are cutting costs, doing more digitally and are looking down the barrel of a lift in investment income.

17/03/2022 Morningstar Investment Management's global CIO Dan Kemp explains why well-intentioned investors desperate for peace in Europe are making dangerous market calls

15/03/2022 Knowledge of the local market, strong branding and a growing subscription service should see the undervalued retailer retain market share in the rapidly growing online sales category, says Roy Van Keulen.

08/03/2022 Higher inflation, rising interest rates and booming commodity markets are driving a major rotation away from the post-pandemic winners, says Tim Murphy, Morningstar director of manager selection.

03/03/2022 Regulators are likely to be less lenient now the buy-now-pay-later sector is part of the fabric of Australian payments.

23/02/2022 Strong commodity prices, cheap valuations and a head start on interest rate hikes means emerging markets are set for strength, says Dr. Joseph Lai of Ox Capital.

23/02/2022 A belligerent speech from a president signalled the start of the latest phase of Russian agression last night, causing markets to wobble and investors to wonder.

15/02/2022 In an extended interview, Morningstar's Peter Warnes discusses the bear market in US technology stocks, interest rates and growth and his approach to investing outside the US and Australia.

13/02/2022 Morningstar equity analyst Shaun Ler explains why he see valuation upside high for MFG even as shares lose steam.

31/01/2022 The Chinese lunar year is almost over, and what a ride it's been. Morningstar speaks to JPMorgan Asset Management strategist Mike Bell about what's ahead.

23/01/2022 Christine Benz discusses how investors should handle the turmoil, whatever the life stage.

18/01/2022 Empty shelves will negatively impact supermarkets in the second half of fiscal 2022 but the impact on long-term earnings is minimal, says Morningstar analyst Johannes Faul.

17/01/2022 Bank earnings, house prices and China risk: Our experts and analysts discuss what they've got their eyes on in 2022.

24/12/2021 Our experts and analysts weigh in on what mattered for investors last year.

21/12/2021 New products, lower fees and a portfolio of undervalued stocks set to help the fund manager right the ship.

10/12/2021 And how does it match up against gold?

10/12/2021 Australian miners to be among the last standing as coal use fades.

08/12/2021 Rebalancing your portfolio is one of those beneficial habits that’s easy to let slide. But year-end is an ideal time to check how your portfolio is tracking against your target asset allocation.

03/12/2021 The gold-rated fund manager shares three ideas with long-term potential.

01/12/2021 Long-term investor sees opportunities where businesses are moving towards a zero-carbon future faster than governments.

30/11/2021 To understand your fund, get to know its underlying index.

29/11/2021 These companies are set to profit from the move to clean energy, says Lazard.

24/11/2021 The results of the COP26 climate summit suggest coal demand is likely to persist for longer than expected.

17/11/2021 And how investors can protect their portfolios.

08/11/2021 Morningstar thinks these moaty companies will remain resilient in the face of inflation and ongoing supply chain challenges.

05/11/2021 Morningstar maintains fair value despite a fall in margins and slower progress on cost reductions.

19/10/2021 These new US-listed exchange-traded funds will invest in bitcoin futures, not bitcoin itself.

15/10/2021 The ESG outperformance narrative is flawed, new research shows.

06/10/2021 Investors may need to hold more growth assets over the coming years, says Morningstar's Jody Fitzgerald.

01/10/2021 And how G8 Education and Link Administration are positioned for long-term success.

30/09/2021 What Reporting Season August 2021 told investors about the health of the financials sector.

28/09/2021 a2 milk is an opportunity to be greedy when others are fearful.

23/09/2021 Covid's winners and losers are returning to their prior trajectories.

21/09/2021 Sequence-of-returns risk matters for both retirees and savers. Here's why.

20/09/2021 Analysts expect the sector to recover to pre-Covid trading levels once borders reopen.

15/09/2021 Rising customer deposits and access to cheap funding helped Australia's banks stave off net interest margin pressure, but analysts see warning signs.

14/09/2021 Morningstar's Hortense Bioy on how to spot greenwashing and how to avoid it.

13/09/2021 Utilities and infrastructure names battle the impact of covid as private equity and pension funds circle.

10/09/2021 Hydrocarbons poised for a comeback.

09/09/2021 Providers have lifted prices after years of a debilitating chase for subscribers at all costs , says Morningstar's Brian Han.

08/09/2021 What shorting ETFs means for long-term investors.

07/09/2021 Morningstar senior analyst Grant Slade says Brambles secular growth trend is intact despite nearterm headwinds. He discusses results from the building and construction materials sector.

03/09/2021 Miners bask in the glow of iron ore prices while bargains remain in coal.

23/08/2021 Post-merger Woodside would be well positioned to deliver on the value we've seen for a long time, say Morningstar analysts.

16/08/2021 But the sector lacks uniformity, says Morningstar's Christopher Franz.

11/08/2021 Higher wholesale electricity prices bode well for AGL, according to Morningstar senior equities analyst Adrian Atkins.

11/08/2021 Morningstar FundInvestor editor Russ Kinnel describes some direct and indirect hedges for inflation protection.

10/08/2021 Copper and iron ore have benefited materially from China’s stimulus and the developed world recovery. But Morningstar analyst Mat Hodge see these benefit as transitory.

05/08/2021 We believe the transaction has a high chance of succeeding.

03/08/2021 The industry still has significant growth potential.

03/08/2021 Is one of the biggest sponsors of the Olympics positioned for an all-electric future?

23/07/2021 Morningstar's Lex Hall talks micro-cap stock picks with Carlos Gil, chief investment officer at Microequities Asset Management.

22/07/2021 Mornngstar's Lex Hall catches up with Carlos Gil, chief investment officer at Microequities Asset Management.

21/07/2021 The head of Australian small and mid-cap stocks at First Sentier Investors has her eye on ARB, Breville and IDP Education.

20/07/2021 The strong performances of global stock markets in 2020–21 are unlikely to be repeated in the coming year says Morningstar's Peter Warnes.

12/07/2021 Morningstar equity analysts warn that equities remain overvalued despite Australia's strong economic recovery.

08/07/2021 Private equity is an exciting area for investors, with lots of hotly-tipped stocks. But there are risks to be aware of, says Pitchbook analyst Dylan Cox.

08/07/2021 Warryn Robertson is looking at French infrastructure, retail pharmacy and tax services.

06/07/2021 Australia's largest banks have excess capital because they cut dividends, were more conservative on lending, divested assets and raised equity last year. Morningstar's Nathan Zaia thinks most of it should be returned to shareholders.

02/07/2021 PEXA burst onto the ASX this week in the biggest float since 2019. Morningstar's Gareth James gives his take on the company's future growth prospects.

30/06/2021 Iron ore prices have been on a tear, boosting the profits of Australia's top miners. How did we get here and is the only way up? Lex Hall sits down with Morningstar's Mat Hodge.

28/06/2021 Morningstar has recently initiated coverage of a food delivery app and a consumer finance product.

24/06/2021 Meeting the deluge of demand is the biggest task for US companies, says Bell Asset Management's Ned Bell.

22/06/2021 Are there still opportunities in the biotech sector now the covid-19 vaccine roll out is underway? We ask International Biotechnology Trust manager Ailsa Craig

21/06/2021 Morningstar's director of Asia equity research is confident the e-commerce giant will bounce back.

18/06/2021 A wide moat and attractive dividend potential are among the key takeaways of Woolworth's decision to demerge from the liquor and hospitality group.

15/06/2021 Lazard Asset Management's Warryn Robertson explains how companies in the Global Equity Franchise fund have adjusted to covid, and assesses the threat of rising inflation.

11/06/2021 Magellan's Craig Wright tells Emma Rapaport why it is leading the charge in the active ETF arena and how its global equity product works.

10/06/2021 Callum Burns of ICE Investors explains his conviction in pharmaceutical distributor Ebos, PSC Insurance Group, and elite sports analytics provider Catapult.

09/06/2021 Callum Burns explains how ICE Investors identifies companies with original products and sticky customer bases.

08/06/2021 They’re building an empire.

07/06/2021 A year ago the oil price went negative. How have oil giants handled the past 12 months and what's the outlook from here? Morningstar analyst Allen Good explains.

04/06/2021 As the investment world goes crazy for crypto, Morningstar Investment Management's Dan Kemp explains what to consider before putting it in your portfolio

03/06/2021 The airline sector is set to recover as international travel resumes. Morningstar analysts think Wizz Air offer the best opportunity among low-cost carriers.

28/05/2021 4D Infrastructure's Sarah Shaw outlines the investment case for Spanish multinationals Cellnex, and Iberdrola, and the potential of Mexican airports.

28/05/2021 The SEC continues to sort out its regulatory concerns.

27/05/2021 We’re raising our fair value as sales hit new highs—but investors need to put it in perspective, says Andrew Willis.

25/05/2021 Covid-19 has enhanced rather than impeded the future for global infrastructure, says Sarah Shaw of 4D Infrastructure.

24/05/2021 Tribeca's Jun Bei Liu also explains why she sees opportunity in sleep apnea specialist ResMed as well as Treasury Wine Estates.

19/05/2021 American Century Investment's Patricia Ribeiro sees growth in Chinese battery technology, biologics, and building materials in Latin America.

18/05/2021 Robotics is a fast-growing area of tech, creating opportunities in medical, logistics and life sciences sectors and much more.

18/05/2021 Square's Bitcoin purchase is more marketing than operations

10/05/2021 If Elon Musk ends up delivering, we might need to raise our fair value to US$1500 a share.

07/05/2021 Banks and resources are poised to deliver dividends, and Treasury Wine Estates and BNPL are worth a look, says Jun Bei Liu of Tribeca's Alpha Plus long/short fund.

05/05/2021 Digital banking, ecommerce and 5G are among the key trends set for rapid growth, says Patricia Ribeiro of American Century Investments.

04/05/2021 Analysts have made changes to the fixed interest, property, cash and equity allocations of Morningstar's Model ETF Portfolios to take advantage of the current market environment. They've also refreshed some of the funds in the portfolio.